Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   HTML views PDF downloads Totals
21,911 Dovepress* 12,706+ 1,932 14,638
PubMed Central* 9,205 1,203 10,408
Totals 21,911 3,135 25,046
*Since 14 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
16 1 0 0 4 11

View citations on PubMed Central and Google Scholar